WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001025194) DRUG TARGET ISOGENES: POLYMORPHISMS IN THE 5-HYDROXYTRYPTAMINE (SEROTONIN) RECEPTOR 1B GENE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/025194    International Application No.:    PCT/US2000/027486
Publication Date: 12.04.2001 International Filing Date: 05.10.2000
IPC:
C12Q 1/68 (2006.01)
Applicants: GENAISSANCE PHARMACEUTICALS, INC. [US/US]; Five Science Park, New Haven, CT 06511 (US) (For All Designated States Except US).
CHOI, Julie, Y. [US/US]; (US) (For US Only).
DENTON, Richard, Rex [US/US]; (US) (For US Only).
NANDABALAN, Krishnan [IN/US]; (US) (For US Only).
STEPHENS, Joel, Claiborne [US/US]; (US) (For US Only)
Inventors: CHOI, Julie, Y.; (US).
DENTON, Richard, Rex; (US).
NANDABALAN, Krishnan; (US).
STEPHENS, Joel, Claiborne; (US)
Agent: SHTIVELBAND, Inna; Genaissance Pharmaceuticals, Inc., Five Science Park, New Haven, CT 06511 (US)
Priority Data:
60/158,114 07.10.1999 US (Priority Withdrawn 08.05.2001)
Title (EN) DRUG TARGET ISOGENES: POLYMORPHISMS IN THE 5-HYDROXYTRYPTAMINE (SEROTONIN) RECEPTOR 1B GENE
(FR) ISOGENES CIBLES DE MEDICAMENTS: POLYMORPHISMES DANS LE GENE DU RECEPTEUR 1B DE 5-HYDROXYTRYPTAMINE (SEROTONINE)
Abstract: front page image
(EN)Polynucleotides comprising one or more of 3 novel single nucleotide polymorphisms in the human 5-hydroxytryptamine (serotonin) receptor 1B (HTR1B) gene are described. Compositions and methods for detecting one or more of these polymorphisms are also disclosed. In addition, various genotypes and haplotypes for the HTR1B gene that exist in the population are described.
(FR)L'invention concerne des polynucléotides contenant un ou plusieurs de 3 nouveaux polymorphismes mononucléotidiques dans le gène du récepteur 1B de 5-hydroxytryptamine (sérotonine) (HTR1B). L'invention concerne également des compositions et des méthodes de détection d'un ou de plusieurs de ces polymorphismes ainsi que divers génotypes et haplotypes pour le gène HTR1B existant dans la population.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)